Home > Analytics > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Intrinsic Value | Fundamental Analysis

BOM : 543322     NSE : GLS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
Apr 12,2024
Price(EOD): ₹ 809.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 9,913.93 Cr
Value of ₹ 1 Lac invested in GLENMARK LIFE SCIENCES
on Aug 06,2021 (price: ₹ 748.20)

₹ 1 L

₹ 1.08 L

1W : 4.3% 1M : -13.3% 1Y : 82.6%
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
GLENMARK LIFE SCIENCES 4.3% -13.3% 82.6%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

FUNDAMENTAL ANALYSIS OF GLENMARK LIFE SCIENCES

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF GLENMARK LIFE SCIENCES

 
Valuation Score
[As on : Apr 12,2024 ]

Ratio Standalone
P/E
P/B
P/S
19.09
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 519.31 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

4.65
P/B Calculated based on Book Value of Rs 2,131.52 Cr
[Latest Year - Mar2023 - Standalone Results ]

4.19
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 14% undervalued companies ! Discover More →

FAIR VALUE OF GLENMARK LIFE SCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
70%
64%
49%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF GLENMARK LIFE SCIENCES



GLENMARK LIFE SCIENCES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF GLENMARK LIFE SCIENCES

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF GLENMARK LIFE SCIENCES

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF GLENMARK LIFE SCIENCES

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-3.79%
3.28%
1.11%
0.02%
5.93%
18.63%
13.85%
13.12%
QtrlyTrend
6
Latest Qtr: Dec2023
Quarterly Result Analysis →


GLENMARK LIFE SCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 0.4% 2.7% 66.6%
S&P BSE ALLCAP 0.3% 1.5% 41.5%
S&P BSE SMALL CAP 0.2% 2.7% 65.5%
S&P BSE HEALTHCARE -0.7% 1.1% 58.7%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 1.1% 3.5% 70.6%
NIFTY MID SMALL400 0.9% 3.2% 64.4%
NIFTY500 MULTICAP 50:25:25 0.6% 2.1% 49.2%
NIFTY 500 0.4% 1.5% 40.6%

You may also like the below Video Courses


FAQ about GLENMARK LIFE SCIENCES


Is GLENMARK LIFE SCIENCES good for long term investment?

As on Apr 12,2024, the Fundamentals of GLENMARK LIFE SCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of GLENMARK LIFE SCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is GLENMARK LIFE SCIENCES UnderValued or OverValued?

As on Apr 12,2024, GLENMARK LIFE SCIENCES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of GLENMARK LIFE SCIENCES ?

As on Apr 12,2024, the Intrinsic Value of GLENMARK LIFE SCIENCES is Rs. 492.65 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 476.09
Fair Value [Median EV / Sales Model] : Rs. 492.65
Fair Value [Median Price / Sales Model] : Rs. 542.64
Estimated Median Fair Value of GLENMARK LIFE SCIENCES : Rs. 492.65

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is GLENMARK LIFE SCIENCES trading at a Premium or Discount?

As on Apr 12,2024, GLENMARK LIFE SCIENCES is trading at a Premium of 64% based on the estimates of Median Intrinsic Value!